Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis
ABSTRACT. Alzheimer disease (AD) is a neurodegenerative disorder. Evidence suggests that AD shares pathophysiological similarities with type 2 diabetes. Intranasal insulin (INI) has emerged as a potential therapeutic approach for AD by directly targeting the brain and modulating insulin signaling pa...
Saved in:
| Main Authors: | Luís Jesuíno de Oliveira Andrade, Gabriela Matos, Luís Matos de Oliveira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Associação Neurologia Cognitiva e do Comportamento
2025-04-01
|
| Series: | Dementia & Neuropsychologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642025000100304&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal administration of stem cell derivatives for the treatment of AD animal models: a systematic review and meta-analysis
by: Zilin Hua, et al.
Published: (2025-07-01) -
Safety and efficacy of topical insulin in ocular surface disorders: a systematic review and meta-analysis
by: Luís J. de Oliveira-Andrade, et al.
Published: (2025-04-01) -
Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial
by: Carolina L. Haass-Koffler, et al.
Published: (2025-08-01) -
Intranasal acupuncture therapy for allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials
by: Xiao-ying Chen, et al.
Published: (2025-03-01) -
Intranasal insulin for improving cognitive function in multiple sclerosis
by: Scott D. Newsome, et al.
Published: (2025-07-01)